| Dr Paula M Guinnip, MD | |
|
4 E Clark Bass Blvd, Suite 204, Mcalester, OK 74501-4269 | |
| (918) 421-6079 | |
| (908) 421-6077 |
| Full Name | Dr Paula M Guinnip |
|---|---|
| Gender | Female |
| Speciality | Thoracic Surgery |
| Experience | 32 Years |
| Location | 4 E Clark Bass Blvd, Mcalester, Oklahoma |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023239720 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Wagoner Community Hospital | Wagoner, OK | Hospital |
| Entity Name | Missouri Delta Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1508967860 PECOS PAC ID: 1355252891 Enrollment ID: O20040308001306 |
News Archive
Cell biologists at The Johns Hopkins University have teased apart two integral components of the machinery that causes cells to move. Their discovery shows that cellular projections, which act as hands to help a cell "crawl," are apparently always initiated by a network of message-relaying proteins inside the cell.
Researchers have demonstrated a new technology that combines a laser and electric fields to create tiny centrifuge-like whirlpools to separate particles and microbes by size, a potential lab-on-a-chip system for medicine and research.
Unigene Laboratories, Inc. a leader in the design, delivery, manufacture and development of peptide-based therapeutics announced today the dosing of the first subject in a Phase 2 study with an experimental oral parathyroid hormone analog for the treatment of osteoporosis in postmenopausal women.
An automated system developed by researchers from the Regenstrief Institute and Indiana University to help pediatricians focus on the specific health needs of each patient in the short time allotted for preventive care improves autism screening rates by identifying at-risk children at the 24-month visit.
Discovery Laboratories, Inc. today announces financial results for the fourth quarter ended December 31, 2009 and provides a business update.
› Verified 3 days ago
| Entity Name | Landmark Hospital Of Cape Girardeau, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1437105574 PECOS PAC ID: 8729092747 Enrollment ID: O20080312000600 |
News Archive
Cell biologists at The Johns Hopkins University have teased apart two integral components of the machinery that causes cells to move. Their discovery shows that cellular projections, which act as hands to help a cell "crawl," are apparently always initiated by a network of message-relaying proteins inside the cell.
Researchers have demonstrated a new technology that combines a laser and electric fields to create tiny centrifuge-like whirlpools to separate particles and microbes by size, a potential lab-on-a-chip system for medicine and research.
Unigene Laboratories, Inc. a leader in the design, delivery, manufacture and development of peptide-based therapeutics announced today the dosing of the first subject in a Phase 2 study with an experimental oral parathyroid hormone analog for the treatment of osteoporosis in postmenopausal women.
An automated system developed by researchers from the Regenstrief Institute and Indiana University to help pediatricians focus on the specific health needs of each patient in the short time allotted for preventive care improves autism screening rates by identifying at-risk children at the 24-month visit.
Discovery Laboratories, Inc. today announces financial results for the fourth quarter ended December 31, 2009 and provides a business update.
› Verified 3 days ago
| Entity Name | Paula Guinnip Cardiac Services Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538718515 PECOS PAC ID: 0547592438 Enrollment ID: O20210114001526 |
News Archive
Cell biologists at The Johns Hopkins University have teased apart two integral components of the machinery that causes cells to move. Their discovery shows that cellular projections, which act as hands to help a cell "crawl," are apparently always initiated by a network of message-relaying proteins inside the cell.
Researchers have demonstrated a new technology that combines a laser and electric fields to create tiny centrifuge-like whirlpools to separate particles and microbes by size, a potential lab-on-a-chip system for medicine and research.
Unigene Laboratories, Inc. a leader in the design, delivery, manufacture and development of peptide-based therapeutics announced today the dosing of the first subject in a Phase 2 study with an experimental oral parathyroid hormone analog for the treatment of osteoporosis in postmenopausal women.
An automated system developed by researchers from the Regenstrief Institute and Indiana University to help pediatricians focus on the specific health needs of each patient in the short time allotted for preventive care improves autism screening rates by identifying at-risk children at the 24-month visit.
Discovery Laboratories, Inc. today announces financial results for the fourth quarter ended December 31, 2009 and provides a business update.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Paula M Guinnip, MD 1008 N Main St, Sikeston, MO 63801-5044 Ph: (573) 472-7423 | Dr Paula M Guinnip, MD 4 E Clark Bass Blvd, Suite 204, Mcalester, OK 74501-4269 Ph: (918) 421-6079 |
News Archive
Cell biologists at The Johns Hopkins University have teased apart two integral components of the machinery that causes cells to move. Their discovery shows that cellular projections, which act as hands to help a cell "crawl," are apparently always initiated by a network of message-relaying proteins inside the cell.
Researchers have demonstrated a new technology that combines a laser and electric fields to create tiny centrifuge-like whirlpools to separate particles and microbes by size, a potential lab-on-a-chip system for medicine and research.
Unigene Laboratories, Inc. a leader in the design, delivery, manufacture and development of peptide-based therapeutics announced today the dosing of the first subject in a Phase 2 study with an experimental oral parathyroid hormone analog for the treatment of osteoporosis in postmenopausal women.
An automated system developed by researchers from the Regenstrief Institute and Indiana University to help pediatricians focus on the specific health needs of each patient in the short time allotted for preventive care improves autism screening rates by identifying at-risk children at the 24-month visit.
Discovery Laboratories, Inc. today announces financial results for the fourth quarter ended December 31, 2009 and provides a business update.
› Verified 3 days ago